Machine Learning-Based Perivascular Space Volumetry in Alzheimer Disease.
Journal
Investigative radiology
ISSN: 1536-0210
Titre abrégé: Invest Radiol
Pays: United States
ID NLM: 0045377
Informations de publication
Date de publication:
23 Apr 2024
23 Apr 2024
Historique:
medline:
23
4
2024
pubmed:
23
4
2024
entrez:
23
4
2024
Statut:
aheadofprint
Résumé
Impaired perivascular clearance has been suggested as a contributing factor to the pathogenesis of Alzheimer disease (AD). However, it remains unresolved when the anatomy of the perivascular space (PVS) is altered during AD progression. Therefore, this study investigates the association between PVS volume and AD progression in cognitively unimpaired (CU) individuals, both with and without subjective cognitive decline (SCD), and in those clinically diagnosed with mild cognitive impairment (MCI) or mild AD. A convolutional neural network was trained using manually corrected, filter-based segmentations (n = 1000) to automatically segment the PVS in the centrum semiovale from interpolated, coronal T2-weighted magnetic resonance imaging scans (n = 894). These scans were sourced from the national German Center for Neurodegenerative Diseases Longitudinal Cognitive Impairment and Dementia Study. Convolutional neural network-based segmentations and those performed by a human rater were compared in terms of segmentation volume, identified PVS clusters, as well as Dice score. The comparison revealed good segmentation quality (Pearson correlation coefficient r = 0.70 with P < 0.0001 for PVS volume, detection rate in cluster analysis = 84.3%, and Dice score = 59.0%). Subsequent multivariate linear regression analysis, adjusted for participants' age, was performed to correlate PVS volume with clinical diagnoses, disease progression, cerebrospinal fluid biomarkers, lifestyle factors, and cognitive function. Cognitive function was assessed using the Mini-Mental State Examination, the Comprehensive Neuropsychological Test Battery, and the Cognitive Subscale of the 13-Item Alzheimer's Disease Assessment Scale. Multivariate analysis, adjusted for age, revealed that participants with AD and MCI, but not those with SCD, had significantly higher PVS volumes compared with CU participants without SCD (P = 0.001 for each group). Furthermore, CU participants who developed incident MCI within 4.5 years after the baseline assessment showed significantly higher PVS volumes at baseline compared with those who did not progress to MCI (P = 0.03). Cognitive function was negatively correlated with PVS volume across all participant groups (P ≤ 0.005 for each). No significant correlation was found between PVS volume and any of the following parameters: cerebrospinal fluid biomarkers, sleep quality, body mass index, nicotine consumption, or alcohol abuse. The very early changes of PVS volume may suggest that alterations in PVS function are involved in the pathophysiology of AD. Overall, the volumetric assessment of centrum semiovale PVS represents a very early imaging biomarker for AD.
Identifiants
pubmed: 38652067
doi: 10.1097/RLI.0000000000001077
pii: 00004424-990000000-00211
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflicts of interest and sources of funding: The authors have declared that no conflict of interest exists. This work was supported by the Deutsche Forschungsgemeinschaft (DFG German Research Foundation) through projects EXC-2047/1-390685813 and EXC2151-390873048 and by the EU–Joint Programme for Neurodegenerative Disease Research through project 01ED2208.
Références
Plog BA, Nedergaard M. The glymphatic system in central nervous system health and disease: past, present, and future. Annu Rev Pathol. 2018;13:379–394.
Bakker EN, Bacskai BJ, Arbel-Ornath M, et al. Lymphatic clearance of the brain: perivascular, paravascular and significance for neurodegenerative diseases. Cell Mol Neurobiol. 2016;36:181–194.
Wardlaw JM, Benveniste H, Nedergaard M, et al. Perivascular spaces in the brain: anatomy, physiology and pathology. Nat Rev Neurol. 2020;16:137–153.
Yu L, Hu X, Li H, et al. Perivascular spaces, glymphatic system and MR. Front Neurol. 2022;13:844938. doi:10.3389/fneur.2022.844938.
doi: 10.3389/fneur.2022.844938
Weller RO, Hawkes CA, Kalaria RN, et al. White matter changes in dementia: role of impaired drainage of interstitial fluid. Brain Pathol. 2015;25:63–78.
Lane CA, Hardy J, Schott JM. Alzheimer's disease. Eur J Neurol. 2018;25:59–70.
Wen SW, Wong CHY. Aging- and vascular-related pathologies. Microcirculation. 2019;26:e12463.
Groeschel S, Chong WK, Surtees R, et al. Virchow-Robin spaces on magnetic resonance images: normative data, their dilatation, and a review of the literature. Neuroradiology. 2006;48:745–754.
Francis F, Ballerini L, Wardlaw JM. Perivascular spaces and their associations with risk factors, clinical disorders and neuroimaging features: a systematic review and meta-analysis. Int J Stroke. 2019;14:359–371.
Zhu YC, Tzourio C, Soumaré A, et al. Severity of dilated Virchow-Robin spaces is associated with age, blood pressure, and MRI markers of small vessel disease: a population-based study. Stroke. 2010;41:2483–2490.
Zhu YC, Dufouil C, Mazoyer B, et al. Frequency and location of dilated Virchow-Robin spaces in elderly people: a population-based 3D MR imaging study. Am J Neuroradiol. 2011;32:709–713.
Heier LA, Bauer CJ, Schwartz L, et al. Large Virchow-Robin spaces: MR-clinical correlation. Am J Neuroradiol. 1989;10:929–936.
Chen W, Song X, Zhang Y. Assessment of the Virchow-Robin spaces in Alzheimer disease, mild cognitive impairment, and normal aging, using high-field MR imaging. Am J Neuroradiol. 2011;32:1490–1495.
Lynch KM, Sepehrband F, Toga AW, et al. Brain perivascular space imaging across the human lifespan. Neuroimage. 2023;271:120009.
Ramirez J, Berezuk C, McNeely AA, et al. Visible Virchow-Robin spaces on magnetic resonance imaging of Alzheimer's disease patients and normal elderly from the Sunnybrook dementia study. J Alzheimers Dis. 2015;43:415–424.
Ramirez J, Berezuk C, McNeely AA, et al. Imaging the perivascular space as a potential biomarker of neurovascular and neurodegenerative diseases. Cell Mol Neurobiol. 2016;36:289–299.
MacLullich AM, Wardlaw JM, Ferguson KJ, et al. Enlarged perivascular spaces are associated with cognitive function in healthy elderly men. J Neurol Neurosurg Psychiatry. 2004;75:1519–1523.
Patankar TF, Mitra D, Varma A, et al. Dilatation of the Virchow-Robin space is a sensitive indicator of cerebral microvascular disease: study in elderly patients with dementia. Am J Neuroradiol. 2005;26:1512–1520.
Banerjee G, Kim HJ, Fox Z, et al. MRI-visible perivascular space location is associated with Alzheimer's disease independently of amyloid burden. Brain. 2017;140:1107–1116.
Paradise M, Crawford JD, Lam BCP, et al. Association of dilated perivascular spaces with cognitive decline and incident dementia. Neurology. 2021;96:e1501–e1511.
Hilal S, Tan CS, Adams HHH, et al. Enlarged perivascular spaces and cognition: a meta-analysis of 5 population-based studies. Neurology. 2018;91:e832–e842.
Cumurciuc R, Guichard JP, Reizine D, et al. Dilation of Virchow-Robin spaces in CADASIL. Eur J Neurol. 2006;13:187–190.
Hurford R, Charidimou A, Fox Z, et al. MRI-visible perivascular spaces: relationship to cognition and small vessel disease MRI markers in ischaemic stroke and TIA. J Neurol Neurosurg Psychiatry. 2014;85:522–525.
Yao M, Zhu YC, Soumaré A, et al. Hippocampal perivascular spaces are related to aging and blood pressure but not to cognition. Neurobiol Aging. 2014;35:2118–2125.
Gertje EC, van Westen D, Panizo C, et al. Association of enlarged perivascular spaces and measures of small vessel and Alzheimer disease. Neurology. 2021;96:e193–e202.
Shi X, Zhou N, Sun B, et al. Perivascular space predicts brain hypometabolism of individuals with underlying amyloid pathology. J Alzheimers Dis. 2022;90:1329–1337.
Potter GM, Chappell FM, Morris Z, et al. Cerebral perivascular spaces visible on magnetic resonance imaging: development of a qualitative rating scale and its observer reliability. Cerebrovasc Dis. 2015;39(3–4):224–231.
Ferguson SC, Blane A, Perros P, et al. Cognitive ability and brain structure in type 1 diabetes: relation to microangiopathy and preceding severe hypoglycemia. Diabetes. 2003;52:149–156.
Wang ML, Zou QQ, Sun Z, et al. Associations of MRI-visible perivascular spaces with longitudinal cognitive decline across the Alzheimer's disease spectrum. Alzheimers Res Ther. 2022;14:185.
Valenzuela MJ, Sachdev P. Assessment of complex mental activity across the lifespan: development of the lifetime of experiences questionnaire (LEQ). Psychol Med. 2007;37:1015–1025.
Jessen F, Spottke A, Boecker H, et al. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE). Alzheimers Res Ther. 2018;10:15.
Jessen F, Amariglio RE, Van Boxtel M, et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease. Alzheimers Dement. 2014;10:844–852.
Molinuevo JL, Rabin LA, Amariglio R, et al. Implementation of subjective cognitive decline criteria in research studies. Alzheimers Dement. 2017;13:296–311.
Albert MS, DeKosky ST, Dickson D, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:270–279.
Jack CR, Albert MS, Knopman DS, et al. Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:257–262.
Wolfsgruber S, Kleineidam L, Guski J, et al. Minor neuropsychological deficits in patients with subjective cognitive decline. Neurology. 2020;95:E1134–E1143.
Mohs RC, Knopman D, Petersen RC, et al. Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study. Alzheimer Dis Assoc Disord. 1997;11(Suppl 2):S13–S21. Available at: https://journals.lww.com/alzheimerjournal/Fulltext/1997/00112/Development_of_Cognitive_Instruments_for_Use_in.3.aspx.
Pfeffer RI, Kurosaki TT, Harrah CH, et al. Measurement of functional activities in older adults in the community. J Gerontol. 1982;37:323–329.
Washburn RA, Smith KW, Jette AM, et al. The Physical Activity Scale for the Elderly (PASE): development and evaluation. J Clin Epidemiol. 1993;46:993–162.
Forstmeier S, Maercker A, van den Bussche H, et al. Motivational reserve: motivation-related occupational abilities and risk of mild cognitive impairment and Alzheimer disease. Psychol Aging. 2012;27:353–363.
Buysse DJ, Reynolds CF 3rd, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–195.
McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group⋆ under the auspices of department of health and human services task force on Alzheimer's disease. Neurology. 1984;34:939–944.
Roman G, Tatemichi T, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies report of the NINDS-AIREN international workshop. Neurology. 1993;43:250–260.
Matheus MG, Castillo M, Smith JK, et al. Brain MRI findings in patients with mucopolysaccharidosis types I and II and mild clinical presentation. Neuroradiology. 2004;46:666–672.
Laveskog A, Wang R, Bronge L, et al. Perivascular spaces in old age: assessment, distribution, and correlation with white matter hyperintensities. Am J Neuroradiol. 2018;39:70–76.
Piantino J, Boespflug EL, Schwartz DL, et al. Characterization of MR imaging-visible perivascular spaces in the white matter of healthy adolescents at 3 T. Am J Neuroradiol. 2020;41:2139–2145.
Heinzinger N, Maass A, Berron D, et al. Exploring the ATN classification system using brain morphology. Alzheimers Res Ther. 2023;15:50.
Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822–838.
Frangi AF, Niessen WJ, Vincken KL, et al. Multiscale vessel enhancement filtering. In: Medical Image Computing and Computer-Assisted Intervention—MICCAI vol. 1496. Berlin, Germany: Springer; 1998:130–137.
Ronneberger O, Fischer P, Brox T. U-Net: Convolutional Networks for Biomedical Image Segmentation. MICCAI. 2015. Published online 2015. doi:10.48550/arXiv.1505.04597.
doi: 10.48550/arXiv.1505.04597
Kingma DP, Lei Ba J. ADAM: A Method for Stochastic Optimization. 3rd International Conference for Learning Representations. Published online 2015. 10.48550/arXiv.1412.6980
Van Veluw SJ, Biessels GJ, Bouvy WH, et al. Cerebral amyloid angiopathy severity is linked to dilation of juxtacortical perivascular spaces. J Cereb Blood Flow Metab. 2016;36:576–580.
Sepehrband F, Barisano G, Sheikh-Bahaei N, et al. Volumetric distribution of perivascular space in relation to mild cognitive impairment. Neurobiol Aging. 2021;99:28–43.
Kamagata K, Andica C, Takabayashi K, et al. Association of MRI indices of glymphatic system with amyloid deposition and cognition in mild cognitive impairment and Alzheimer disease. Neurology. 2022;99:E2648–E2660.
Iliff JJ, Nedergaard M. Is there a cerebral lymphatic system? Stroke. 2013;44(6 Suppl 1):S93–S95.
Jessen NA, Munk ASF, Lundgaard I, et al. The glymphatic system: a beginner's guide. Neurochem Res. 2015;40:2583–2599.
Ringstad G, Valnes LM, Dale AM, et al. Brain-wide glymphatic enhancement and clearance in humans assessed with MRI. JCI Insight. 2018;3:e121537.
Roher AE, Kuo YM, Esh C, et al. Cortical and leptomeningeal cerebrovascular amyloid and white matter pathology in Alzheimer's disease. Mol Med. 2003;9:112–122.
Jiang Q, Lee CY, Mandrekar S, et al. ApoE promotes the proteolytic degradation of Aβ. Neuron. 2008;58:681–693.
Reddy OC, van der Werf YD. The sleeping brain: harnessing the power of the glymphatic system through lifestyle choices. Brain Sci. 2020;10:868.
Berezuk C, Ramirez J, Gao F, et al. Virchow-Robin spaces: correlations with polysomnography-derived sleep parameters. Sleep. 2015;38:853–858.
Dubost F, Yilmaz P, Adams H, et al. Enlarged perivascular spaces in brain MRI: automated quantification in four regions. Neuroimage. 2019;185:534–544.
Boutinaud P, Tsuchida A, Laurent A, et al. 3D segmentation of perivascular spaces on T1-weighted 3 tesla MR images with a convolutional autoencoder and a U-shaped neural network. Front Neuroinform. 2021;15:641600.
Lian C, Zhang J, Liu M, et al. Multi-channel multi-scale fully convolutional network for 3D perivascular spaces segmentation in 7 T MR images. Med Image Anal. 2018;46:106–117.